How to improve RD productivity: The pharmaceutical industry's grand challenge

Steven M. Paul, Daniel S. Mytelka, Christopher T. Dunwiddie, Charles C. Persinger, Bernard H. Munos, Stacy R. Lindborg, Aaron L. Schacht

Research output: Contribution to journalReview articlepeer-review

2225 Scopus citations

Abstract

The pharmaceutical industry is under growing pressure from a range of environmental issues, including major losses of revenue owing to patent expirations, increasingly cost-constrained healthcare systems and more demanding regulatory requirements. In our view, the key to tackling the challenges such issues pose to both the future viability of the pharmaceutical industry and advances in healthcare is to substantially increase the number and quality of innovative, cost-effective new medicines, without incurring unsustainable RD costs. However, it is widely acknowledged that trends in industry RD productivity have been moving in the opposite direction for a number of years. Here, we present a detailed analysis based on comprehensive, recent, industry-wide data to identify the relative contributions of each of the steps in the drug discovery and development process to overall RD productivity. We then propose specific strategies that could have the most substantial impact in improving RD productivity.

Original languageEnglish
Pages (from-to)203-214
Number of pages12
JournalNature Reviews Drug Discovery
Volume9
Issue number3
DOIs
StatePublished - Mar 2010

Fingerprint

Dive into the research topics of 'How to improve RD productivity: The pharmaceutical industry's grand challenge'. Together they form a unique fingerprint.

Cite this